Groningen, Netherlands · Founded 2021 · Privately Held (backing)
Developer of intravenous line infusion monitoring services intended to improve patient safety in neonatal and pediatric intensive care. Sencilia is based in Groningen, Netherlands and was founded in 2021. It has raised $860,000.
Last price · $/share
—
Implied valuation
—
Total raised
$860K
Last round
—
Cap table — not yet on record
Sencilia's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Sencilia with a free account
·The complete investor list: 14 names
·Watch Sencilia: the Monday email on marks, rounds and moves
